|
|
|
- 左 蒲
- 9 years ago
- Views:
Transcription
1 Sihuan Pharmaceutical Holdings Group Ltd. (a) (b) (c) (d) (e) 32 2(1 (f) (g) (h) (i) (j) (k) (l)
2
3 7.2% 7.3% 7.4% 2, , % % 78.7% 79.1% 83.0% 66.5% 60.1% 57.3% 57.7%
4 % % % % % , , , , , , , , , , , , , , , (1)... 4, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , (2)... 14, , , , , , , , , , , , , , , , , , , , , , , (3)... 1, , , % 510, % 708, % 322, % 473, % (1) (2) Feidiao Pudiao Quxinao (3)
5 % % % % % (1) , , , , , , , , , , , , , , , , % 510, % 708, % 322, % 473, (1) 2, , % 3,600 55% 5,
6 %
7 GMP GMP [2010] % MSPEA III Cayman China Pharma
8 MSPEA III Cayman MSPEA Pharma BVChina Pharma China Pharma China Pharma 76.6% MSPEA Pharma BV China Pharma (a) (b) MSPEA Pharma BV China Pharma 48,672, China Pharma China PharmaChina Pharma China Pharma China Pharma
9 48,672, MSPEA Pharma BV MSPEA Pharma BV MSPEA Pharma BV 48,672, ,000,000 10% Plenty Gold MSPEA Pharma BV Plenty Gold Top Matrix Top Matrix Plenty Gold 42,300,000 9% NHC NHCNHC NHC NHC , , , , , , , , , ,051 1,173,442 1,363, ,214 18,997 29,995 10, , , , , , , , , , ,051 1,173,442 1,363, , , , , , , ,182 1,183,431
10 , , , , , (60,526) (133,551) (191,915) (90,696) (127,074) , , , , , ,744 (8,014) (16,348) (29,151) 19, (22,732) (38,906) (48,810) (22,634) (26,364)... (38,856) (53,405) (78,809) (35,276) (52,420)... (2,527) 470 5, , ,427 2,357 2, , , , , , (5,626) (53,621) (67,370) (36,335) (42,683) , , , , , , , , , , (440) (3,611) (12,660) (8,758) (7,437) 178, , , , ,
11 , , , , , (155,731) (115,365) 16,062 61,098 (2,526) ,758 (72,656) (120,029) (71,558) (173,939)... 41, , , , , , , , , ,378 [ ]
12 API API
13
14
15
16 10320
17 China Pharma China Pharma Limited Plenty Gold China Pharma 32 MSPEA Pharma BV Plenty Gold Plenty Gold Plenty Gold CPL China Pharma
18 60% 20% 20% GDP Euromonitor International
19 IMS IMS Health Incorporated IMS IMS 60% 17% 23% 51% 34% 10% 5% API MENET
20 MSPEA III Morgan Stanley Private Equity Asia III, L.P. MSPEA III Cayman Morgan Stanley Private Equity Asia III Holdings (Cayman) Ltd MSPEA III Coop MSPEA III Coop MSPEA III Holdings Coöperatief U.A. MSPEA Pharma BV MSPEA III GP Morgan Stanley Private Equity Asia III, L.L.C. MSPEA III Inc. Morgan Stanley Private Equity Asia III, Inc. MSPEA Pharma MSPEA Pharma Holdings B.V. BV % Plenty Gold Plenty Gold Enterprises Limited 51% 25% 11% 10.1% 2.9%Plenty Gold
21 A.
22
23 Top Matrix Top Matrix Enterprises Limited Sihuan Management (PTC) Limited Plenty Gold S
24 API
25 GMP
26 GSP
27
28
29 66.5% 60.1% 57.3% 57.7% 62.0% 50.8% 46.7% 45.6% [2010] % 30.6% 27.7% 23.4% Harbin Tri-Lion Pharmaceutical Co., Ltd. 25.2% 34.3% 28.0%
30 Harbin Tri-Lion Pharmaceutical Co., Ltd
31 600 (Spanish Committee on Drug Surveillance)
32 % 73.8% 72.9% 73.2% 62.5% 45.8% 44.2% 52.3% 50.2% 50.2% API API API API API
33 84.7% 68.1% 63.6% 45.3% API API API API 43.1 API API API API API API 65.1% GMP
34 API API
35
36 30.0% 21.6% 19.6% 16.9% API
37 [2007]42 [2009]387 [2010] % 1, API 2, , , ,
38 3, , ,
39
40 11,000 9,000 24,000 44,000
41 China Pharma 2,019,922131,600 2,019, ,600
42 93.8% 86.8% 81.5% 80.6% [2010] %
43 API 3.9% 14.2%
44 31
45 25%
46 25% 25% 10% 10%
47 10% 25% 5% 10% 1.1
48 (i)(ii) (iii) 5 15
49
50 (a) (b) (c)
51 2.0% 1.5%3.0%
52
53 [ ] 8A A Eddy Huang 17 10A
54 41A A
55 Clarendon House 2 Church Street P.O. Box HM1022 Hamilton HM DX Bermuda BCD Eddy Huang
56 Codan Services Company Limited Claredon House, PO Box HM 1022 Hamilton HM DX Bermuda
57 IMS [ ] [ ] [ ] [ ] IMS IMS[ ] IMS IMS100 IMS -IMSIMS IMS IMS 1,072 2, % IMS 6, %
58 IMS IMS 3, %12.6% %2.2% IMS
59 IMS70% 24.0% 19.8% IMS IMS 72% IMS IMS IMS
60 40.4% 34.9%24.7% 60.0%
61 % % % % % % % % % % IMS 85% 20, ,280 5,110 6,523 1,233 IMS 48.6% 38.6% 4.3% 8.6%
62 % % , , , , , , , , , , , , , , , , , , Euromonitor Euromonitor 4.1%
63 % 10,49317, % Economist Intelligence Unit35.8% 44.0% % 77.4% % %
64 90% 8,500 IMS8,500 46% 90% IMS IMS 47% 5,0002,0002,400 IMS
65 IMS (i) (ii) (iii) (iv) (v) 68.3% IMS20% (%)... 66, , , , , , , , , , , , , , , , , , , , IMS
66 % MENET % IMS % 1.4% 1.8% % 0.7% 1.0% % 2.6% 5.5%
67 31, % 10.8% IMS IMS 28, , %
68 36.4%26.9% 28.5% IMS 26.6% 7.4% (%) IMS
69 IMS (%) (%) GM1... 1, , , , , IMS (%) IMS
70 IMS 25.8% 899 IMS
71 500 1,300 IMS % (%) (%)... 1, , , IMS IMS IMS
72 MENET 600 IMS % (%) (%) GM1... 1, , IMS IMS IMS
73 IMS IMS 56 [ ] IMS IMS IMS 1 IMS IMS IMS 100 IMS
74 28% % 20 15%
75 MSPEA III Cayman API 60% 40% 20% 20% 20%
76 51% 25% 11% 13% 75% 30% 50% 20% 300, , ,000 30% 25% 20% 75% 25% 75% 25% 750, ,000 9,520,000 28% 8% 5%
77 17% 40%2% % 49% 10% 90% 10%100,000 10% 10% 51% 25% 11% 13% 58,616,800
78 [ ] 49% 49%2,484, (i)(ii) (iii) 60% 40% 2,254, ,503, GSP
79 60% 80% 20% 800,000 20% 4,000,00050,000,000 8,500,000 37,500,000 75% 17% 8% 62,500,000 15% 60% 45% 45% 50,715,000
80 45% [ ] 14.8% 51.9% 2.3% 0.27% 25%[ ] 17.2% 27.8% 38,872,000 62,828, (1)(a) 4.05A (a) 45%
81 (b) 16(c) (d) 51% 34% 10% 5% API MSPEA III Cayman China Pharma MSPEA Pharma BV(1) China PharmaChina Pharma Plenty Gold
82 60% 4 60% 20% ,000 41% 20% MSPEA III Cayman Plenty Gold69% Plenty Gold 51% 25% 11% 10.1% 2.9% 2.2% 2.1% 1.4% 2% 23.3% MSPEA III Cayman MSPEA Pharma BV China Pharma China Pharma
83 China Pharma MSPEA Pharma BV MSPEA Pharma BV MSPEA III Coop MSPEA III Coop MSPEA III Cayman MSPEA III Cayman MSPEA IIIMSPEA III MSPEA III GP MSPEA III GP MSPEA III Inc. China Pharma 76.6% MSPEA Pharma BV China Pharma (a) MSPEA Pharma BV China Pharma 48,672, China Pharma (b) China PharmaChina Pharma China Pharma China Pharma 48,672, MSPEA Pharma BV MSPEA Pharma BV MSPEA Pharma BV 48,672, ,000,000 10% Plenty Gold MSPEA Pharma BV [ ]
84 China Pharma Plenty Gold China Pharma 95% China Pharma Plenty Gold % % % MSPEA Pharma BV % % Plenty Gold Top Matrix Top Matrix Plenty Gold 42,300,000 9% NHC NHC Top Matrix New Horizon Capital III L.P. NHC NHC NHC Plenty Gold % % % MSPEA Pharma BV % Top Matrix % %
85 NHC MSPEA Pharma BV (a) Plenty Gold MSPEA Pharma BV Top Matrix Eddy Huang (b) MSPEA Pharma BV Top Matrix (i) Plenty Gold (ii) Plenty Gold (c) MSPEA Pharma BV Top Matrix (d) MSPEA Pharma BV Top Matrix (e) MSPEA Pharma BV NHC Plenty Gold NHC NHC Top MatrixPlenty Gold [ ]Top Matrix Top Matrix [ ] Plenty Gold Top Matrix NHC NHC Top Matrix PlentyGold
86 Plenty Gold Top Matrix Top Matrix Plenty Gold 42,300, ,465,589Top Matrix NHC160% Plenty Gold 73,764,80853,700,781 Plenty Gold Top Matrix [ ] Top MatrixPlenty Gold Plenty Gold MSPEA Pharma BV Top Matrix Top Matrix Top Matrix Plenty GoldMSPEA Pharma BV Top Matrix Top Matrix MSPEA Pharma BV[ ] MSPEA Pharma BV Plenty Gold [ ] 41,212,900 75,200 32,900 Plenty Gold [ ]
87 Plenty Gold % % % MSPEA Pharma BV % Top Matrix % % %
88 (1) MSPEA Pharma BVMSPEA III Coop MSPEA III Coop MSPEA III Cayman MSPEA III Cayman MSPEA IIIMSPEA III MSPEA III GP MSPEA III GP MSPEA III Inc. (2) Plenty Gold 51% 25% 11% 10.14% 2.86% (3) 61%
89 IMS 7.2% 7.3% 7.4% 2, , % %, 78.7%, 79.1% 83.0% % 9.1% 7.8% 6.5% % 12.0% 12.0% 10.4% 66.5% 60.1% 57.3% 57.7%
90 % % % % % (1) , , , , , , , , , , , , , , , , % 510, % 708, % 322, % 473, % (1) 2,000 31
91 10, % 3,600 55% 5, % GMP GMP
92 % % % Sanofi-Aventis Pfizer 17.1% 58.1% 2, , % 3,60055% 5,400
93 , , % 4,668
94 22.9% %
95
96 500 90% 80% 70%
97 GMPFDA
98 (2) (1) (1) (1) (1)
99 (2) (1) (1) [2007]42 [2009]387 [2010]394 (2) % 29.2%
100 % % % % % , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , % % 29 2,500 80
101 0.0093% % 2, %
102 66.5% 60.1% 57.3% 57.7% % 58.1% 120
103 % 22.4% GM1 GM1 GM1 GM1 1, % GM1 GM1 1, %
104 % 27.1% % % % % %... 4, , , , , , , , , , , , , , % 14.3% 13 1, %
105 % % % % % %... 3, , , , , (1)... 14, , , , , , , , , , (1) Feidiao Pudiao Quxinao 1530
106 1, % 238.8%COS Feidiao Pudiao Quxinao % % 2,000 10,
107 ,000 GSP 2, %3,60055%5,400
108 GSP (i) (ii) (iii)
109 0.004% 0.004% GSP GSP
110
111 (1) (2) (3) 1,594 1,773 2,398 2,022
112 30.0% 21.6% 19.6% 16.9% 12.3% 7.4% 6.2% 4.6% 3.9% 14.2% [2010] % 10.6% 0.3%
113 1) 1) 1) 1) 2) 2) 2) 2) 3) 3) 3) 3) 4) 4) 4) 4) 5) 5) 5) 5)
114
115 (i)(ii) (iii) (iv) 23 CCV
116 % , , , , ,000 36,370 48,203 50, % 7.1% 6.8% 10.7% (1)... 4,394 8,435 13,697 9, ,355 5,851 15,617 9, ,927 14,369 7,264 19, ,324 4,344 5,666 9, ,371 5,959 2,687 (1)
117 30 10
118 182.5% EvaluatePharma 12
119 20 2,800, , , , ,000 3,500,000 7,300,000 15,000,000 GMP 25,329 15,305 GMP
120 (1 (%) (%) (%)... 3,000,000 1,760, ,020, (2) 3,030, (2)... 62,500,000 26,810, (3) 35,810, ,270, ,000,000 49,120, ,100, ,450, ,000, ,000, ,000, ,000, ,000,000 3,160, ,390, ,030, (1) 250 (2) 100% (3) 2,8006,
121 % 68.1% 63.6% Harbin Tri-Lion Pharmaceutical Co., Ltd. 25.2% 34.3% 28.0% 51%
122 21 11 GMP
123 % 30.6% 27.7% % % 69.6% 54.2% % 2.1% 6.1% 8.3%
124 26 GSP GMP GMP
125 28,000 20,000 6,000 GSP GMP
126
127 IMS 3, % 2.2%
128 100 BayerSimcere Pharmaceutical GroupGM1 58.1% Hefei Pingguang Pharmaceutical Co., Ltd. 16.4% 22.4% Ebewe Pharma Ges.m.b.H. Nfg. KG 41.7% 5.0% 3.2% Heilongjiang Harbin Medical University Pharmaceutical Co., Ltd. GMIGM159.8% 23.0% 7.9% 14.3% 12.8% 8.8% 13.6% Zhejiang Jianfeng Pharmaceutical Co., Ltd. Guilin Aolin Pharmaceutical Co., Ltd. 46.8% 28.1% 4.3% Beijing Kaiyin Pharmaceutical Co., Ltd. Beijing Huasu Pharmaceutical Co., Ltd. 17.1% 9.9% 5.4% Boehringer Ingelheim International Trading Co., Ltd. Shenyang New Horse Pharmaceutical Co., Ltd. 33.4% 15.4%
129 72, ,138.0
130 23, , , API 2, API 5 API 150,000 API 100,000 50,000 10, , , , , ,000
131 65, , , , , ,000 API
132 10
133 GMP GMP
134 51 (3) 1. H H (4) 80 (1) 2. H (4) (1) (2) Z Z H H (1) 20 (4) 5. (1) H (1) H H (1) H H (4) 9. H H (4) 11. H (4) 12. H (4) 13. H (1) H H (1) H H H H H
135 (3) 19. H H H (4) 22. H H H H H H H H (1) H H H H H H H H H
136 (3) 38. H H (4) 40. H (4) 41. H (4) 42. H H H (4) 45. H (1) (1999)X-28 H H (5) 48. H H H H (1) (2) (3) (4)
137 (3) 1. H H (2) 50 (4) H (4) H (4) 2. (1) H H (4) H (4) H (4) 3. (2) H H (4) H (4) 4. H H (2) (4) 5. 1 H (4) H (4) 6. H H Z (4) 8. (2) Z Z (4) 9. (2) H H (4) H (4) 10. (2) H H (4)
138 (3) H (4) 2.25 H (4) 2:1 H (0.75 ) (4) H (4) H (4) H (4) H (4) 13. H H (2) 14. H H H H H (2) (4) 17. H (4) H (4) 18. H H H (4) H (4) 20. (2) H H
139 (3) 21. H (4) 22. H (4) 23. H H H ( ) H H (4) H (4) H (4) H (4) H (4) 26. H (4) H (4) H (4) 27. H H (4) 29. H (4) 30. ( H ) 15 H H (4) 32. Z (4)
140 (3) 33. H H H H H H H H (1) (2) (3) (4) API
141 [2007]42 [2009]387 [2010]394
142 GMP Jing G0153 L5157 Jing G0181 Jing I0275 I4396 Jing J0356 GMP
143 12 300,000 (i) 122(1) (ii) 122(1A) China Pharma 2,019, ,600 China Pharma China Pharma China Pharma
144 China Pharma [2006]27 [1999] % 18% 20% 22%2007(39) 11%22% [2007] 39 [2007]39 [2009]69 [2009]69 [2007]39 25% [2009]69[2007] %
145 [2010]15715% 12.5% 15% 9% 10% 11%... 33% 25% 25% 25% (1) % 15% 15% 15% (2) % 12.5% 12.5% (3) % 18% 20% 22% (4) % 9% 10% 11% (1) (2010)15715% (2) (2009)69 (3) (2007)39 (4)
146 15% 23,800, , ,000
147 % % % % % % (i) (ii) (iii)
148 (iv)
149 Plenty Gold [ ] [ ] [ ][ ]
150 (i) (ii) 5% (i) 30%; (ii) (iii) (i) (ii)
151 (iii) (i) (iv) (v) (vi) (vii) (i) 30% (ii)
152 [ ] Eddy Huang
153
154 48 39 Morgan Stanley Private Equity Asia 691 China Flooring Holding Company Limited Morgan Stanley Private Equity Asia Simpson Thacher & Bartlett Eddy Huang35 Morgan Stanley Private Equity Asia Eddy Huang Morgan Stanley Private Equity Asia
155 Financial Institutions Investment Banking Group CIMIC Industrial Group Ltd Solomon Systech International Limited
156 (i) (ii) (iii)13.51(2)(h) 13.51(2)(v) (iv) (v) 13.51(2)
157 () 41 Shenzhen Tong Yun Group Wuhan Ma Ying Long Pharmaceutical Co., Ltd.Wuhan Ma Ying Long Chained Pharmacies Co., Ltd. 35 Titan Chemicals Corp. Bhd.
158 Titan Petrolchemicals (M) Sdn. Bhd. Nelson PolytechnicNelson Marlborough Institute of Technology
159 SOHO
160 TJCC IMM C3
161 B
162 % % % % % % Plenty Gold [ ] Plenty Gold [ ]
163 [ ] Plenty Gold 4,230,000 30% [ ] 2 BC 89
164 [ ] [ ]%
165 7.2% 7.3% 7.4% 2, , % % % IMS 1,072 2, %
166 8,500 IMS 6, % IMS (i) (ii)(iii) (iv) (v) IMS % 36.4%IMS %
167 (i) (ii) % 30.6% 27.7% 23.4% 2, ,
168 (i) (ii) (i)(ii) (iii) (iv) 44 19
169 % 85.8% 81.5% 80.6%
170 4 2
171 10.0%
172 , , , , , (60,526) (133,551) (191,915) (90,696) (127,074) , , , , , ,744 (8,014) (16,348) (29,151) 19, (22,732) (38,906) (48,810) (22,634) (26,364)... (38,856) (53,405) (78,809) (35,276) (52,420)... (2,527) 470 5, , ,427 2,357 2, , , , , , (5,626) (53,621) (67,370) (36,335) (42,683) , , , , , , , , , , (440) (3,611) (12,660) (8,758) (7,437) 178, , , , ,
173 82.3% 78.7% 79.1% 83.0% % 77.7% 76.2% 78.2% % % % % % , , , , , , , , , , , , , , , (1)... 4, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
174 % % % % % (2)... 14, , , , , , , , , , , , , , , , , , , , , , , (3)... 1, % 7, % % % , % 510, % 708, % 322, % 473, % (1) (2) Feidiao Pudiao Quxinao (3) % 69.8% 66.2% 66.5% 66.2% % % % 9.3% % %
175 % % % (i) (ii) (iii) (3) % 67.3% 66.2% 65.0% 68.3% % 30.6% 27.7% (1) 29.8% 23.4% (1) (2) % 2.1% 6.1% 5.2% 8.3% % 100.0% 100.0% 100.0% 100.0% (1) (2) (3)
176 30.0% 21.6% 19.6% 16.9% 12.3% 7.4% 6.2% 4.6%
177 ... 33, , , , , , , , , , , , , , , , , , , , , % 133, % 191, % 90, % 127, % % 73.8% 72.9% % 71.9% (i) (ii)
178 % % % % % , , (1) 456, (1) 208, , (1)... 21, , , , , , , , , , (1) 1.3% 0.6% 0.6% 0.2%
179 ... 3,717 3,149 4,393 1, ,969 12,076 19,453 9,577 18, (930) (22,805) (80,261) (80,261)... 38,201 38, , (1,535) (238)... (1,737) (1)... (264) 2,838 2,104 1, ,744 (8,014) (16,348) (29,151) 19,444 (1)... (22,732) (38,906) (48,810) (22,634) (26,364)... (38,856) (53,405) (78,809) (35,276) (52,420)... (2,527) 470 5, , (64,115) (91,841) (121,975) (57,733) (75,712)
180 % 7.6% 6.9% 5.6%... 18,776 29,386 33,674 16,032 15, ,265 3,771 7,304 3,125 4, ,464 4,402 6,752 2,840 3,745 (1) ,347 1, , ,732 38,906 48,810 22,634 26,364 (1) 4.0% 3.8% 3.3% 3.2%
181 60% % 10.5% 11.1% 11.1%... 4,394 8,435 13,697 4,031 9, ,280 18,877 26,594 13,712 17, ,627 8,258 13,471 5,007 6, ,822 7,799 10,473 4,332 3, ,989 4,134 4,217 1,203 4,599 (1)... 5,744 5,902 10,357 6,991 10, ,856 53,405 78,809 35,276 52,420 (1) 0.9% 0.1% 0.8% 0.6%
182 ... (3,622) (3,706) (493) (1,053) (1,039)... 1,271 4,259 6,236 1,287 4, (176) (83) (99) (57) (46)... (2,527) 470 5, , % % 18.7% 17.7% 14.7% 15.0% 25.0% 15.0% 15.0% 11.5
183 % %393.0 (i)(ii) % % % % % 3.8% % % %10.4
184 % % % % % 73.2% (i) (ii) % % % 5.6% % 52.4
185 % % % 14.7% % %254.8
186 % % % 560.6(i) (ii) (iii) % % % % %0.4% % % % % 33.6
187 % 16.1 Quxinao % % % 72.9% % % %6.9%
188 % % % % % 17.7% % 313.7
189 % % % % 401.4(i) (ii) % % % % % % % % 133.6
190 % % 73.8% % % 7.6% %
191 % % (i)15.0% 7.5%15% (ii) % 18.7% % % % 3.6
192 , , , , , (155,731) (115,365) 16,062 61,098 (2,526) ,758 (72,656) (120,029) (71,558) (173,939)... 41, , , , , , , , , ,378
193
194 (i) 20.1 (ii)18.6 (i)45%32.0 (ii) % (i)56.7 (ii)8.3 (iii) 48.3 (1) 6.0 (iv) (i)39.8 (a) 61.9 (2) 31.9 (b) 48.3 (1) 6.0 (c) 1.9 (3) (ii) 35.7(iii)29.5
195 (iv) (i)55.9 (ii)45.0(a) 61.9 (2) 30.0 (b)15.0 (iii) 48.3 (1) 36.3 (iv) China Pharma (1) (2) (3)
196 ,839 29,452 56,677 18, ,927 14,624 8,295 20, , ,766 44,076 68,710 38, ,953 39,395 42,967 49, ,714 71, , , , , , , , , , , ,826 89, ,391 94, ,693 37,643 98,869 85, , , , , , , , , ,271
197
198 ,119 4,228 2,542 2,989 (1)... (138) (138) (138) (138)... 2,981 4,090 2,404 2,851 (2)... 6,289 27,202 63,878 87,001 (3)... 15,444 40,132 42,850 46,728 (4) , , ,714 71, , ,519 (1) (2) (3) (4) China Pharma China Pharma [ ] China PharmaChina Pharma
199 % 3.3% 5.4% 4.6%
200 ... 8,267 7,761 17,876 13, ,100 4,235 3, ,750 30,534 20,856 31, ,953 39,395 42,967 49,
201 (1)... 8,859 4,187 12,675 8, ,250 2,938 1, (2)... 13,671 20,804 49,535 18, ,959 7,157 8,652 18, ,000 6,000 (3)... 3,690 7,044 12,000 20,950 (4)... 2,354 (5)... 24,397 39,067 36,159 27, ,826 89, ,391 94,261 (1) (2) (3) [ ]9.0 (4) (5)
202 (1) (2) (3) (1) 360 (2) 360 (3)
203 (1)... 1, (2)... 23,089 23,089 (3)... 2,739 2, ,264 3,398 23, (1) (2) (3)
204
205 545.7
206
207 3.340 I IV II10 9
208 3.340 I IV II II2
209 I. 6 78, , , , , , , , ,576 16,234 18,843 18, , ,144 40, , , , , , ,953 39,395 42,967 49, ,714 71, , , , , , , , , , , , ,051 1,173,442 1,363, ,262 69,262 69,262 69, , , , , ,626 75, , , , , , , , , ,503 1,162,352 14,644 16,684 10, , , ,187 1,172, ,214 18,997 29,995 10, ,826 89, ,391 94, ,693 37,643 98,869 85, ,000 95, , , , , , , , , ,051 1,173,442 1,363, , , , , , , ,182 1,183,431
210 10 208, , , , ,002 36,349 35,049 35, ,244 49,396 26,258 19, ,246 85,745 61,307 55, , , , , ,262 69,262 69,262 69, , , , , ,781 24,283 (4,554) (18,774) 302, , , , ,911 17,908 22,307 30,991 14,911 17,908 22,307 30, , , , ,388 94,335 67,837 39,000 24, , , , ,397
211 20 286, , , , , (60,526) (133,551) (191,915) (90,696) (127,074) 225, , , , , ,744 (8,014) (16,348) (29,151) 19, (22,732) (38,906) (48,810) (22,634) (26,364) 21 (38,856) (53,405) (78,809) (35,276) (52,420) 186, , , , , ,271 4,259 6,236 1,287 4, (3,798) (3,789) (592) (1,110) (1,085) (2,527) 470 5, , ,427 2,357 2, , , , , , (5,626) (53,621) (67,370) (36,335) (42,683) 178, , , , , , , , , ,849 (440) (3,611) (12,660) (8,758) (7,437) 178, , , , ,
212 54,413 24,775 68,601 2, , ,266 (440) 178, , , , (10,429) (10,429) 29(b) (2,221) (2,221) 16 20,851 (20,851) 69, ,909 45, , ,813 69, ,909 45, , , ,059 (3,611) 233,448 18,255 18, (60,656) (60,656) 16 29,629 (29,629) 69, ,909 75, ,790 14, ,860 69, ,909 75, ,790 14, , ,316 (12,660) 313,656 14,700 14, (120,029) (120,029) 16 34,330 (34,330) 69, , , ,747 16, ,187 69, , , ,747 16, , ,849 (7,437) 247,412 1,071 1,071 69, , , ,596 10,318 1,172,670 69, ,909 75, ,790 14, , ,594 (8,758) 110, (71,558) (71,558) 69, ,909 75, ,826 5, ,138
213 27 193, , , , ,900 (11,150) (26,082) (53,290) (26,801) (57,916) 182, , , , ,984 9 (35,715) 9 69,700 69,700 32, (45,000) 29 (36,305) (39,833) (6,000) 19 14, (2,485) (24,684) 37,936 (30,839) (29,452) (56,677) (5,049) (18,580) (55,927) (14,624) (8,295) (4,840) (20,122) (3,738) 1,271 4,259 6,236 1,287 4,157 (155,731) (115,365) 16,062 61,098 (2,526) (173,939) 197,758 (60,656) (120,029) (71,558) (4,000) (12,000) 193,758 (72,656) (120,029) (71,558) (173,939) 220,592 68, , ,874 7,519 41, , , , , , , , , ,378
214 II. 1. China Pharma Limited China Pharma China Pharma Plenty Gold Enterprises Limited Plenty Gold Clarendon House, 2 Church Street, P.O. Box HM 1022, Hamilton HM DX, Bermuda (a) 12,000 12, Plenty Gold Plenty Gold Plenty Gold51% 25% 11% 13% 12,000 12,000,000 12,000 7,500,000 Plenty Gold (b) 51% 25% 11% 13% 58,617,000 Hainan Sanpu Pharmaceutical Development Co., Ltd Hainan Sanpu
215 (c) Hainan Sanpu Hainan Sanpu Hainan Sanpu (d) ,000, ,000, ,500, ,000, ,187,00095,000,000 9,400, ,000, (e) 2,485,000 49% 51% 100% (f) 60,000,000 (g) 1 11 (h) 3,758,000
216 (i) 62,500,00060% (j) 50,715,000 45% 101,700,000 45% (k) China Pharma China Pharma (l) 51% (m) (n) (o) 4,000,000 60% (p) 61% 41% 20%
217 % % % % %
218
219 9 2.2 (a) (b)
220 (c) 20% 50% (a)
221 (b)
222 2.6 (a) (b) (i) (ii) (iii) (iv) 5 10
223 (c) (a) 12 (b)
224
225
226 2.19 (a) (b) (c)
227 (a) (i) 14 (ii) (iii)
228 262, , , , , , , ,378 (b)
229 (c) 800,271, ,378, ,155 14,911 12,000 67,155 14,911 68,747 17,908 70,856 22,307 75,414 30,
230 (a) 10% 826, , , , , , , ,000
231 (b) ,117,000 12,130,000 49,107,000 13,990,000 15,933,000 7 (c) (d) 5.
232 6. 48,189 14,757 1,622 5,605 4,056 74,229 (14,978) (4,611) (652) (996) (21,237) 33,211 10, ,609 4,056 52,992 33,211 10, ,609 4,056 52, ,150 4, ,534 22,801 30,839 2,471 (2,471) (302) (302) (2,733) (1,699) (327) (603) (5,362) 34,179 13,208 1,571 5,331 24,386 78,675 51,890 19,518 2,550 6,530 24, ,874 (17,711) (6,310) (979) (1,199) (26,199) 34,179 13,208 1,571 5,331 24,386 78,675 34,179 13,208 1,571 5,331 24,386 78, , ,520 3,864 3,375 1,156 2,630 18,427 29,452 18,136 1, (20,080) (30) (30) (4,354) (2,551) (545) (880) (8,330) 68,372 15,931 2,693 7,558 22, ,287
233 92,740 25,018 4,431 9,646 22, ,568 (24,368) (9,087) (1,738) (2,088) (37,281) 68,372 15,931 2,693 7,558 22, ,287 68,372 15,931 2,693 7,558 22, ,287 31,069 6,849 1,317 1,548 15,894 56, (874) (21) (185) (28) (234) (6,458) (3,398) (922) (916) (11,694) 92,962 19,197 3,934 8,190 37, , ,681 30,631 6,220 11,194 37, ,479 (30,719) (11,434) (2,286) (3,004) (47,443) 92,962 19,197 3,934 8,190 37, ,036 92,962 19,197 3,934 8,190 37, , , ,794 5,025 18,580 31, (31,727) (4) (46) (50) (3,893) (2,280) (435) (841) (7,449) 121,289 27,457 4,233 9,097 11, , ,901 41,152 6,954 12,917 11, ,975 (34,612) (13,695) (2,721) (3,820) (54,848) 121,289 27,457 4,233 9,097 11, ,127
234 3,525 4,067 4,017 2,032 1, ,820 4,231 7,654 4,630 5,561 5,362 8,330 11,694 6,672 7, ,151 57,186 1,222 88,853 (17,644) (146) (17,790) ,507 57,186 1,076 71, ,507 57,186 1,076 71, ,836 28,000 33,000 72, ,697 55, (494) (b) (930) (930) (1,400) (7,150) (98) (8,648) 12,130 26,600 39, , ,248 12,130 28,000 63, ,389 1, ,616 (1,400) (24,794) (244) (26,438) (930) (930) 12,130 26,600 39, , ,248
235 12,130 26,600 39, , , ,977 31,000 67,977 9,089 5, ,624 (a) (6,000) (6,000) 125 (125) (1,535) (1,535) (b) (2,800) (20,005) (22,805) (5,600) (11,008) (510) (17,118) 49,107 21,000 34, , ,391 49,107 28,000 73, ,009 1, ,682 (7,000) (35,802) (754) (43,556) (2,800) (20,935) (23,735) 49,107 21,000 34, , ,391 49,107 21,000 34, , , ,724 1,031 8,295 1,965 (1,965) (238) (238) (b) (35,117) 1,737 (46,881) (80,261) (5,600) (9,971) (155) (15,726) 13,990 15,400 28,758 77,952 1, ,461 49,107 28,000 75, ,768 2, ,722 (12,600) (45,773) (892) (59,265) (35,117) (1,063) (67,816) (103,996) 13,990 15,400 28,758 77,952 1, ,461 13,990 15,400 28,758 77,952 1, , ,943 1,943 10,000 9, ,122 (2,800) (5,777) (132) (8,709) 15,933 12,600 32,981 87,849 1, ,817
236 51,050 28,000 85, ,665 2, ,787 (15,400) (51,550) (1,024) (67,974) (35,117) (1,063) (67,816) (103,996) 15,933 12,600 32,981 87,849 1, ,817 (a) 6 (b) 12,000,000 7,150 11,008 9,971 5,687 5,777 1,498 6,110 5,755 2,878 2,932 8,648 17,118 15,726 8,565 8,709
237 ,836 13,696 13,696 13,696 35,117 1,943 12,130 49,107 13,990 15,933 48% 46% 37% 12% 15% 15% 44% 41% 50% 37% 12% 48% 15% 15% 30% 45% 40% 37% 12% 15% 15% 31% 37% 37% 12% 15% 15%
238 8. 7,982 (1,024) 6,958 6,958 (382) 6,576 7,982 (1,406) 6,576 6, ,600 (942) 16,234 18,582 (2,348) 16,234
239 16,234 3,738 (1,129) 18,843 22,320 (3,477) 18,843 18,843 (564) 18,279 22,320 (4,041) 18, ,715 10,427 61,142 2,357 (63,499) 45% 50,715,000 15,000, ,231,000
240 45% 101,700,000 38,201, , ,735 1,036,068 31,649 45% , , , , ,000, ,000, ,267 7,761 17,876 13, ,100 4,235 3,787 13,750 30,534 20,856 31,660 22,953 39,395 42,967 49,298
241 50,251, ,702, ,885,000 77,556, ,030, ,119 4,228 2,542 2,989 (138) (138) (138) (138) 2,981 4,090 2,404 2,851 6,289 27,202 63,878 87,001 15,444 40,132 42,850 46, ,939 1,238 32,000 27,002 35,959 34,670 33,952 24,714 71, , ,519 27,002 36,349 35,049 35,891 China Pharma China Pharma China Pharma III
242 12 3 2,795 3,868 2,160 2, ,119 4,228 2,542 2, , , , , , , , , , , , ,
243 , , , ,215 82,244 49,396 26,258 19, ,000 40, , , , , ,378 82,244 49,396 26,258 19, % 1.85% 2.74%
244 180, , , ,345 82,226 49,380 11,648 7,119 82,226 49,380 11,602 7,098 13,859 17,700 13,859 12, , , , ,378 82,244 49,396 26,258 19, % 0.99% 0.81% 0.97% ,000 12,000 7,500 54,413 54, , ,500 95,000 14, , ,187 (10,429) (10,429) 600,000 12, ,000 69, , ,171 12,000 12, ,000,000 12,000, ,488,000 1
245 1 5012,000, ,000, ,500, ,000, ,187,00095,000,000 9,400, ,000, ,775 68,601 93, , ,266 20,851 (20,851) 45, , , , ,059 (60,656) (60,656) 29,629 (29,629) 75, , , , ,316 (120,029) (120,029) 34,330 (34,330) 109, , , , , , , ,181 75, , , , ,594 (71,558) (71,558) 75, , ,081
246 (1,097) 50,781 24,283 24,283 (4,554) 51,878 34,158 91,192 49,616 (14,220) (60,656) (120,029) (71,588) 50,781 24,283 (4,554) 2,311 (18,774) 10% 50% 17. 8,859 4,187 12,675 8,526 2,250 2,938 1, , ,671 20,804 49,535 18,847 3,959 7,157 8,652 18,635 12,000 6,000 3,690 7,044 12,000 20,950 3,690 7,044 12,000 20,950 2,354 24,397 39,067 36,159 27, ,027 10,027 10,027 10,027 68,826 89, ,391 94,261 14,911 17,908 22,307 30,991
247 6 6,678 3,034 10,800 7, , ,147 1,230 1,081 8,859 4,187 12,675 8, ,000
248 ,144 40,937 1 (8,474) (9,031) (22,469) 4,584 1 (1,740) (9,966) (7,526) 6,177 (10,214) (18,997) (29,995) 10,761 (10,214) (18,997) 28,149 30,176 (683) (10,214) (18,997) (18,997) 28, (9,561) (4,194) (4,589) 47,146 (2,089) 2,027 (10,214) (18,997) 28,149 (21,086) 30,176
249 ,561 9, (30) (30) 10,214 10,214 10,214 10, ,194 4, (2,156) 6,745 4,589 12,252 6,745 18,997 12,252 6,745 18, (2,287) 13,285 10,998 9,965 20,030 29,995 9,965 20,030 29, (1,234) (18,000) (19,234) 8,731 2,030 10,761 10%
250 6,745,000 20,030,0002,030, ,007, ,368, ,486,000 (a)24 58,144 58,144 58, (17,207) 40,937 (a) 4,084,000 6,200,000 29,459,000 24,219,000 1,021,000 1,550,000 7,365,000 6,055,000 4,084,000 6,200,000 29,219,000 24,219,000
251 , , , , ,437 3,717 3,149 4,393 1, ,969 12,076 19,453 9,577 18,226 7 (930) (22,805) (80,261) (80,261) 9 38,201 38,201 13,252 7 (1,535) (238) (1,737) (264) 2,838 2,104 1, ,744 (8,014) (16,348) (29,151) 19,444
252 21. 4,394 8,435 13,697 4,031 9, ,150 11,008 9,971 5,687 5,777 11,544 19,443 23,668 9,718 14, ,362 8,330 11,694 6,672 7, , ,498 6,110 5,755 2,878 2,932 66, , ,342 75, ,386 (15,773) (16,442) 6,543 2,255 (10,356) 22 12,734 25,872 37,369 18,578 28,927 10,394 10,472 12,478 4,661 6,793 20,083 21,214 27,977 13,023 11,276 2,973 4,902 2,060 1, ,399 4,379 5,562 2,375 3,657 2,375 1,974 3,233 1,357 1,928 1, , ,019 2,288 4,429 3,459 5, ,564 11,413 5,670 8, , , , , ,858
253 22. 11,153 22,141 33,595 16,084 25, ,054 2,423 1,426 1, ,677 1,351 1,068 2,249 12,734 25,872 37,369 18,578 28,927 (a) (b) 640 1, , ,242 3,690 4
254 750 3, , , ,615 6, , , ,400 (a) (b) 286 (b) ,548 12, (a) (b)
255 375 4, , , , , , ,200 a (b) 134 (b) , (a) (b)
256 (c) ,000, (3,622) (3,706) (493) (1,053) (1,039) (176) (83) (99) (57) (46) (3,798) (3,789) (592) (1,110) (1,085) 1,271 4,259 6,236 1,287 4,157 (2,527) 470 5, ,072
257 24. (a) (b) (c) 15% 33% 7.5% 25% 18% 20% 22% 25% 15%
258 17,133 49, ,516 34,246 44, (30) 4,589 (47,146) 2,089 (2,027) 17,103 53,621 67,370 36,335 42,683 (a) (11,477) 5,626 53,621 67,370 36,335 42,683 (a) 50% 15% 7.5% 15%
259 184, , , , ,095 31,020 80, ,697 24,367 59,159 (2,607) (589) (589) 3,196 3,196 (663) (888) (653) (291) (451) 6,745 13,285 13,285 2,000 (14,236) (33,414) (72,081) (10,479) (23,434) , ,845 7,581 5,330 4,760 17,103 53,621 67,370 36,335 42,683 19,112 14,693 37,643 37,643 98, ,075 (11,150) (26,082) (53,290) (26,801) (57,916) 17,133 49, ,516 34,246 44,710 (11,477) 14,693 37,643 98,869 45,088 85,663
260 25. (a) 179, , , , , , , , , , (b) ,558 71, ,656 48,471 60, ,029 71,558
261 , , , , , ,362 8,330 11,694 6,672 7, ,648 17,118 15,726 8,565 8, ,805 80,261 80, , , (b) (38,201) (38,201) 20 (13,252) 23 (1,271) (4,259) (6,236) (1,287) (4,157) 9 (10,427) (2,357) (2,357) 185, , , , ,710 (9,535) (16,442) (3,572) (11,208) (6,331) (1,427) (40,077) (37,708) (3,605) (27,331) 19,162 16,277 36,840 11,560 (27,148) 193, , , , ,900
262 (30) (98) (50) (a) 32,500 35,715 2,739 10,409 59,662 31,034 23,089 29, ,877 31,034 25,828 39,741
263 (b) 991 2, , ,129 3,399 1,436 2,624
264 29. (a) (i) 60,000,000 11,695 11,695 5,067 5,067 6,238 6, ,000 16,114 28,000 84,508 39,622 (25,678) (25,678) (9,561) (1,105) (1,105) (36,344) (26,783) 48,164 12,839 48,164 11,836 60,000 (11,695) 48,305 36,305 6,000 6,000 48,305
265 26,384,000 4,639, ,990, ,373,000 (ii) 3,758,000 1,861 1, ,898 1,898 1,898 1,898 1,898 1,860 3,758 (1,861) 1,897 78,620,000 20,688, ,048, ,448,000
266 (iii) 62,500,000 60% ,520 7,288 10,600 4,057 31,000 50,015 60,280 62,520 10,448 10,448 4,194 14,642 10,448 45,638 52,072 60% 27,383 35,117 62,500 (564) (30,000) 31,936 1,280,000 7,768, ,548, ,073,000
267 (iv) 4,000,000 60% 4,019 4, ,146 4,146 (1,018) (1,018) (1,018) (1,018) 3,128 3,128 60% 2,057 1,943 4,000 (4,019) (19) 19, ,437,000246,913,000
268 (b) 49% ,348 1,372 4,903 (370) (370) 4,533 49% 2,221 (2,485) (264)
269 III. 173,939,030 China Pharma 173,939,030 China Pharma
270 IV. III UBS AG [ ]
271 A. B. C.
272
273
274 512
275 B.Sc. FRICS FHKIS [ ] 27 30
276 1. 2,996, % 2,996, ,119, % 32,119, ,802,000 60% 12,481, ,779, % 18,779, B 25C 25D
277 5. 2,161, % 2,161, ,857,000 68,536, ,794, % 3,794, ,526, % 5,526, ,320,000 9,320,000
278 8. 3,989,000 51% 2,034,000 3,989,000 2,034,
279 A
280 16. 5 A 3 1 B A
281 ,166,000 79,890,000
282 1. 2,996, % 48 2,996, HK HK HK HK a.
283 2. 32,119,000 25, , % 32,119, , ,773, (2006 ) 04225, , , , ,604,000
284 7. a. b. 3 c. 42 1,407.4 d. 4 3,452.53
285 3. 20,802, , , % 12,481, % (2002) 1913,348 1,022, (2005) , , ,000
286 6. a. b. 3 c. 4
287 4. 18,779, % ,779,000 25B 25C D ,510,
288 5. 2,161, % ,161, ,135, (2010)
289 6. 3,794, % 3,794, (2004 ) , ,470, X , a. b.
290 7. 5,526, % 48 5,526, HK HK HK HK , a. b.
291 8. 3,989,000 33, , % 2,034, , , ,044, % C ,333 4,380,000
292 2. (2009) , X ,100, a. b. c.
293 , , ,813, ,776,
294 , , ,980, , ,479,
295 , , a. b.
296 12. A ,196 A 2 6 B B 386 A A B 36, A A B 36, A 1, ,052,000
297 4. a. b. B c. 2 3 d e. B
298 % 8, , a b. 2a4 c. d.
299 % 1, , a. b.
300 15. 2, , , a. b. 2
301 A 3 1 B , , a. b. c.
302 A 3 221, , a. b.
303 , , , a. b.
304 , , a. b.
305 , % 1, , , , a. 2 b.
306 , , % 3. a. b. c.
307 1. 42A 2. (a) (i)
308 (ii) (iii) (iv) (v)
309 (vi) (aa) (bb)
310 (cc) (dd) (ee) 5% (ff) (vii)
311 (viii) (14)
312 (ix) (b) (c) (i) (ii)
313 (iii) (iv) (v) (vi) (vii) (d) (e) 21 (10)
314 95%) (21) (10) (f) (g) 15
315 (h) (21)
316 (i) (21) (20) (e) (21) (10) (14) (10) (j)
317 (30) (k) (l) (m) (i) (ii) (a) (b)
318 (n) (o) (20%) (14)
319 (20%) (p) (q) (r) 4(e) (s)
320 (t) (i)312 (ii) 12 (iii) 3 (u) 3. (21)
321 95% (21) 4. (a) (i) (ii) (aa) (bb) (iii)
322 (b) (c) (i)(ii) (iii) (i) (ii)
323 42A (d) (i) (ii) 54 (e)
324 (f) (g) (i) (ii) (iii) (5)
325 (21) (7) (h) (21) (7) (15) (i)
326 (j) (k) (l) (20%)(a) (b) (c) 98(2)(c)
327 (m) (2) (14) (2) 87A (n)
328 1 5. Conyers Dill & Pearman
329 10%
330 10% 10%
331 25% 15% 7.5% 9% 10% 11% 15% 15% 25% 15% 17% 17%
332 5% 16.5%15.0% 0.1% 0.2% 5
333
334 ;
335 G B1 B2 C E A
336 GMP GMPGMP GMP
337 GMP GMP GMP GMP GMP GMP GMP GMPGMP GMP
338 30
339 2
340
341
342
343 30 49% GSP GSPGSP GSP GSP 2004 GSP
344 115% 125%
345
346
347 15%
348 %
349 20
350
351 [ ] 30
352 2009
353
354 A XI [ ] [ ] [ ] (1) [ ] [ ] [ ] [ ] (2) [ ] [ ] [ ] [ ] [ ] [ ] (3) (i) [ ] [ ] [ ] (ii) [ ] (iii) [ ] (iv) [ ]
355 [ ] [ ] [ ] 3. (a) (b) 9,400,000,000 6,000, ,000,000 (c) (d) [ ] [ ] (e) [ ] 20% (f) [ ]20%
356 4. [ ] China Pharma ,000 1,000, , , [ ] (e) [ ] (f) [ ] (g) [ ] [ ] [ ]
357 [ ] B. 1. (a) China Pharma10,000 (b) 38,872, % (c) 62,828, % (d) ,000 41% 20% (e) (f) China Pharma 10,000 China Pharma (g) MSPEA Pharma BV China Pharma
358 (h) (i) (j) (k) (l) China Pharma MSPEA Pharma BV MSPEA Pharma BV Top Matrix (m) Plenty Gold (n) (o) (p) (q) (r) (s) (t) (u) (v) Plenty Gold [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ]
359 2. (a) ZL A ZL ZL ZL ZL ZL ZL IIA
360 ZL ZL ZL ZL ZL X ZL ZL X
361 ZL ZL ZL ZL ZL ZL ZL ZL ZL ZL
362 ZL ZL ZL ZL ZL ZL ZL ZL X ZL ZL
363 ZL ZL X ZL ZL , ZL X ZL B ZL ZL ZL ZL
364 ZL ZL ZL X ZL ZL ZL ZL ZL ZL ZL ZL
365 ZL ZL X ZL ZL ZL ZL X ZL ZL ZL
366 ZL ZL ZL ZL ZL ZL ZL X ZL X ZL ZL , ZL
367
368 ZL Zhongwei Biotechnology Co. Ltd ZL Zhongwei Biotechnology Co. Ltd N ZL Zhongwei X Biotechnology Co. Ltd
369 ZL ZL ZL ZL ZL ZL ZL
370 PCT PCT/CN2008/ PCT PCT/CN2008/ Dong Yanyan
371 X X X
372 B X
373 X
374 X
375 X X
376 X X
377 X X
378 X
379 X PCT PCT/CN 2008/
380 IV IV X DPP-IV IV IV X DPP-IV DPP-IV DPP-IV DPP-IV -IV X -IV IV
381
382 X
383 X X PCT PCT/CN 2008/001532
384 x x X X
385 L X X
386
387 Wu Shenrong Li Youyuan Xiao Sa Wu Shenrong Li Youyuan Xiao Sa Chongqing Fujin Bio- Pharmaceutical Co., Ltd. (1) (2)
388 (b)
389
390
391
392
393
394
395
396
397 (c) bjbiosciences.com kbpbio.com kbpbiosciences.com sihuanpharm.asia sihuanpharm.com sihuanpharm.com.cn sihuanpharm.hk sihuanpharm.kr sihuanpharm.net sihuanpharm.tw
398 szshpharm.com szshpharm.com.cn C. 1. [ ] 2. (a) [ ][ ][ ] [ ] 10% Plenty Gold... [ ] [ ]% MSPEA Pharma BV1... [ ] [ ]% MSPEA III Coop1... [ ] [ ]% MSPEA III Cayman1... [ ] [ ]% MSPEA III1... [ ] [ ]% MSPEA III GP1... [ ] [ ]% MSPEA III Inc1... [ ] [ ]% (1) MSPEA Pharma BVMSPEA III Coop MSPEA III Coop MSPEA III Cayman MSPEA III Cayman MSPEA III MSPEA III MSPEA III GP MSPEA III GPMSPEA III Inc. MSPEA III Coop MSPEA III Cayman MSPEA III MSPEA III GP MSPEA III Inc.MSPEA Pharma BV
399 3. [ ] 100,000 50,000 25,000 Eddy Huang [ ] [ ] 300, , ,
400 (a) [ ] (b) (c) (d) (e) [ ] (f)
401 D , % 100% 200,000, % 6,000, % 1,000, % 1,000,000 60% 700, % 3,000, % 30,353,000 60% 50,000,000 60% 3,000,000 51% 30,000,000
402 100% 3,600, % 2,000, Plenty Gold (a) [ ] (b (c) (a) (b) [ ] [ ] [ ] [ ]
403 5. 6. [ ] 7. [ ] 8. [ ] [ ] 9. (a) (i) (ii) (iii) (iv) (v) (b)
% % % % % (1) , , , , , , , , , ,004
IMS 7.2% 7.3% 7.4% 2,000 31 10,000 14 17.1% 20 30 235.6 401.4 560.6 393.0 82.3%, 78.7%, 79.1% 83.0%17.3 46.2 55.5 30.7 6.0% 9.1% 7.8% 6.5% 33.4 61.2 84.8 49.1 11.7% 12.0% 12.0% 10.4% 66.5% 60.1% 57.3%
280,000, % 0.003% 0.005% C
: 8180 280,000,000 0.25 1% 0.003% 0.005% 0.01 8180 32 342C i 1 www.newraymedicine.com...... 2...... 1. 2. 3. ii ... i... ii... iii... 1... 13... 23... 29... 30... 56... 60... 63... 65... 76... 91... 102...
untitled
SUN EAST TECHNOLOGY (HOLDINGS) LIMITED * 00365 9 39 70 B1B 40 43 48 183 22 * ....................................................... 1.................................................. 9.............................................
ii & iii
342C 993 20 1.5 ...................................................... ii & iii............................................................ 1-4................................................... 5-6......................................................
untitled
UNIS TECHNOLOGY STRATEGY SUN EAST TECHNOLOGY INVESTMENT LIMITED (HOLDINGS) LIMITED * 365 CAPITAL 11 24 25 31 32 3334 52 1 8 18322 * .................................................. ii........................................................
i
YUXING INFOTECH HOLDINGS LIMITED * www.hkgem.com * i .................................................................. 1........................................................... 4...................................................
2 (AHKSA, ACCA) Conyers Dill & Pearman 151 Clarendon House 2 Church Street Hamilton HM 11 Bermuda The Bank of Bermuda Limited Ba
Jiwa Bio-Pharm Holdings Limited * 2004 * 2 (AHKSA, ACCA) Conyers Dill & Pearman 151 Clarendon House 2 Church Street Hamilton HM 11 Bermuda 89 1 2904 2906 515 62 The Bank of Bermuda Limited Bank of Bermuda
HUAJUN INTERNATIONAL LIMITED NEW ISLAND DEVELOPMENT HOLDINGS LIMITED * 377 7 15 16 20 21 22 23 43 33 18 * .......................................................... 1................................................................
01 cover 42830-03D 0..1
此 乃 要 件 請 即 處 理 閣 下 如 對 本 通 函 任 何 方 面 或 應 採 取 之 行 動 有 任 何 疑 問, 應 諮 詢 冊 證 券 商 銀 行 經 理 律 師 專 業 會 計 師 或 其 他 專 業 顧 問 閣 下 之 股 票 經 紀 或 其 他 註 閣 下 如 已 售 出 或 轉 讓 名 下 所 有 中 泛 控 股 有 限 公 司 之 股 份, 應 立 即 將 本 通 函 連 同
(f) (g) (h) (i)
CHINA AUTOMOTIVE INTERIOR DECORATION HOLDINGS LIMITED (a) (b) (c) (d) (e) (f) (g) (h) (i) [ ] [ ] 15,000,000 (1) (2) (3) (4) (5) (6) (7) (8) (9) 1 1. 2. 10099.7 99.7 PE/PP [21.9]%[34.6]% 37.8% [65.9]%[81.0]%
Kong Shum Union Property Management (Holding) Limited 100,000,000 0.5 1% 0.003% 0.005% 0.3 0.01 8181 32 342C 2013 10 7 0.5 0.3 2013 10 7 www.hkgem.com
8181 Kong Shum Union Property Management (Holding) Limited 100,000,000 0.5 1% 0.003% 0.005% 0.3 0.01 8181 32 342C 2013 10 7 0.5 0.3 2013 10 7 www.hkgem.com www.kongshum.com.hk 2013 9 30 www.hkgem.com i
C Ann.indd
115 3 178,575 6,257 (169,868) (4,189) 8,707 2,068 3 54 632 3 330,988 150,371 (461) (850) (28,230) (41,509) 311,058 110,712 4 (6,111) (2,006) 3,567 * 1 308,514 108,706 5 (76,552) (37,534) 7 231,962 71,172
2 3 8 22 30 31 32 33 35 36 38 77 % 2,452 1,983 24% 2,969 2,307 29% 1,103 974 13% (2) 45.0% 49.1% -4.1pp (4) 1,062 407 161% EBITDA (1) 1,556 1,219 28% EBITDA (2) 63.5% 61.5% 2.0pp (1) 472 422 12% (2) 19.2%
(RICI Heath) AR chi.indb
RICI HEALTHCARE HOLDINGS LIMITED : 1526 2016 2 6 8 9 10 12 16 28 48 67 81 88 2017 2017 6 2 2016 6 23 2015 5 20 2014 7 11 2013 11 6 500 2 2014 7 11 (i)(ii) 2015 2 16 2015 6 29 3 2016 10 6 2016 10 6 2008
中國神威藥業集團有限公司
CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED 200,000,000 180,000,000 20,000,000 4.36 1% 0.005% 0.005% 0.002% 0.10 2877 342C 4.36 3.70 4.361%0.005% 0.002%0.005% 3.70 4.36 1 2......... 3...... 48...... (1)
001 40 40 2 3 4 5 6 7 11 14 19 29 34 51 53 54 114 116 002 Clarendon House Church Street Hamilton HM 11 Bermuda 19 25 2505 8 22 11 20 Conyers Dill & Pearman 8 1 2901 Butterfield Fulcrum Group (Bermuda)
9,566 (13,504) (2,343) 2,849 7,223 (10,655) 9,928 (30,948) 5,548 (1,645) (1,637) (13,543) 3,911 (15,188) 350 (1,206) (5,455) (1,206) (5,105) 2,705 (20
Kaisa Health Group Holdings Limited Mega Medical Technology Limited 876 3 226,703 188,140 (113,244) (85,800) 113,459 102,340 19,399 7,422 (43,752) (29,747) (59,457) (60,995) (16,052) (9,768) 4 13,597 9,252
目 錄 頁 碼 定 義... I 董 事 會 函 件... 1 附 錄 I 財 務 信 息... I-1 附 錄 II 一 般 信 息... II-1 1
此 乃 要 件 請 即 處 理 閣 下 對 本 通 函 任 何 方 面 或 對 應 採 取 之 行 動 如 有 任 何 疑 問, 應 諮 詢 閣 下 之 註 冊 證 券 商 銀 行 經 理 律 師 專 業 會 計 師 或 其 他 專 業 顧 問 閣 下 如 已 售 出 或 轉 讓 名 下 全 部 康 哲 藥 業 控 股 有 限 公 司 股 份, 應 立 即 將 本 通 函 送 交 買 主 或 承 讓
[ ] China Art Financial Holdings Limited [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [0.01] [ ] [ ] [ ] [ ] [ ] C [ ] [ ] [ ] [ ] [ ] [ ] [ ] [
![[ ] China Art Financial Holdings Limited [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [0.01] [ ] [ ] [ ] [ ] [ ] C [ ] [ ] [ ] [ ] [ ] [ ] [ ] [](/thumbs/43/23140299.jpg "[ ] China Art Financial Holdings Limited [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [0.01] [ ] [ ] [ ] [ ] [ ] C [ ] [ ] [ ] [ ] [ ] [ ] [ ] [")
China Art Financial Holdings Limited (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) 1933 [ ] China Art Financial Holdings Limited [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [0.01] [ ] [ ] [ ] [ ] [ ] 32
12093.indb
INTERNATIONAL ELITE LTD. 228,000,000 1.36 1% 0.004% 0.005% 0.01 8313 32342C (www.hkgem.com) i www.hkgem.com www.iel.hk........................................................................................................................................
untitled
2356 6 20 21 22 23 55 2016 8 5 4 30510 20 64 66 48 183 17M 2016 7 16 ............................................................ 1...................................................... 6 1........................................................
02 12 14 16 18 23 36 38 41 45 64 81 82 83 85 86 88 90 140 02 301 125 26.74 39% 25% 31% 3 8 4 60 43 2 38% 56% 41% 40,000 5,000 450 35,000 30,000 4,000 360 25,000 3,000 270 20,000 15,000 2,000 180 10,000
Pak Fah Yeow International Limited PAK FAH YEOW INTERNATIONAL LIMITED * 239 4 9 10 11 17 238 3 22 23 200 11 * ............................................................... 1.........................................................
untitled
S S FOSUN INTERNATIONAL LIMITED 00656) www.fosun.comwww.hkexnews.hk 20132013 2013 (i)(ii) 1 2013 2013 2013 2013 2013 2013 2013 www.fosun.com www.hkexnews.hk 2013 2013 2013 2013 2013 2013 2013 S 2 2013
Sau San Tong Holdings (Cayman Islands) Limited * 132,000,000 92,400,000 39,600, C *
Sau San Tong Holdings (Cayman Islands) Limited * 132,000,000 92,400,000 39,600,000 0.25 0.01 8200 342C * www.hkgem.com 2... www.hkgem.com... 1...... 1. 2. 3. 4. ... 1... 4... 5... 5... 8... 10... 11...
untitled
KML Technology Group Limited (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) 32 [ ] KML Technology Group Limited [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ][] [ ] [ ] 1%0.0027% 0.005% [ ] 0.01 [ ] [ ] [ ]
Clarendon House Church Street Hamilton HM 11 Bermuda A2202 Conyers Dill & Pearman MUFG Fund Servi
001 2 3 4 5 9 12 18 29 34 51 53 54 111 112 002 1 2 1 2 1 2 1 2 Clarendon House Church Street Hamilton HM 11 Bermuda 19 25 2505 8 22 22012201A2202 Conyers Dill & Pearman 8 1 2901 MUFG Fund Services (Bermuda)
1 2 6 8 15 19 21 22 24 25 26 43 472 517 65.47 5 3.04 5 2 56 1 472,000,000738,000,000517,000,000 42,000,000 79,000,000 43,000,000 178,000,000 148,000,00020% 45% 551,000,000 9.5% 6.25% 2 386,000,000679,000,000
* 3,000,000, ,000,000 2,700,000, %0.004% 0.005% C %0.004%0.005% (i)144a (ii) 501(a) (iii)s *
* 3,000,000,000 300,000,000 2,700,000,000 1.71 1%0.004% 0.005% 0.01 1387 32 342C 1.711.40 1.711%0.004%0.005% (i)144a (ii) 501(a) (iii)s903904 * (1) (2)................. (3)................ eipowww.eipo.com.hk
new_Chi-3.pdf
The United Laboratories International Holdings Limited 32 342C 2.752.25 2.751%0.004%0.005% 2.75 2.252.75 www.eipo.com.hk (2)..................... (3)..............................................................
02 04 05 07 15 17 18 19 20 41 43 02 GBS, OBE, JP GBS, OBE, JP Conyers Dill & Pearman GBS, OBE, JP GBS, OBE, JP Butterfield Fund Services (Cayman) Limited Butterfield House 68 Fort Street P.O. Box 705,
CHINA CORN OIL Company Limited 1006 09 2 3 4 11 16 26 33 35 36 37 38 39 40 82 Butterfield Fulcrum Group (Cayman) Limited Butterfield House 68 Fort Street P.O. Box 609 Grand Cayman KY1-1107 Cayman Islands
665 2014 2 4 6 10 14 22 42 48 57 74 76 205 206 207 12 31 2014 2013 2,713,291 1,646,814 65 1,018,269 529,152 92 % 1 15.71 12.57 25 56.17 41.07 37 50.42 39.15 29 5.85 4.21 39 3.74 2.99 25 2014 12 31 2013
GenNex Holdings Limited [] [] [] [] [] [] []1.0% 0.0027% 0.005% 0.01 [] [] [] 342C [][] [] [] [][] [][] [][] []
![GenNex Holdings Limited [] [] [] [] [] [] []1.0% 0.0027% 0.005% 0.01 [] [] [] 342C [][] [] [] [][] [][] [][] []](/thumbs/41/22640975.jpg "GenNex Holdings Limited [] [] [] [] [] [] []1.0% 0.0027% 0.005% 0.01 [] [] [] 342C [][] [] [] [][] [][] [][] []")
GenNex Holdings Limited (a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k) GenNex Holdings Limited [] [] [] [] [] [] []1.0% 0.0027% 0.005% 0.01 [] [] [] 342C [][] [] [] [][] www.hkexnews.hkwww.gennexholdings.com
全唐诗28
... 1... 1... 1... 2... 2... 2... 3... 3... 4... 4... 4... 5... 5... 5... 5... 6... 6... 6... 6... 7... 7... 7... 7... 8... 8 I II... 8... 9... 9... 9...10...10...10...11...11...11...11...12...12...12...13...13...13...14...14...14...15...15...15...16...16...16...17...17
(i) (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (x) (xi) 60.99%39.01%
48.55% 1998 19986 30%20086 2009 2009 200 (i) (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (x) (xi) 60.99%39.01% 200820092010 772 928960200820092010 1512928 201 1. 20091222(2009)7267 20042008 16,980,954.02
2 3 4 6 29 32 35 55 64 69 70 71 73 75 76 * * * * 28 12 183 17 1712 16 Appleby Canon s Court 22 Victoria Street Hamilton HM12 Bermuda Weber Shandwick 979 10 8 1602 05 1114 2 5,125,118 4,862,855 5,514,804
®Ñ¥U4.indb
: 1098 07 2 4 6 8 10 13 23 29 30 34 51 57 60 137 139 144 2007 2006 2005 2004 2003 1,282 1,187 1,187 993 815 2,408 506 767 885 864 687 614 2,598 555 66 2,408 552 78 48 119 1,209 786 388 357 334 851 705
00C AR.indb
........................................................................... 2........................................................................... 3....................................................................
untitled
12.032,350 200 GMP : C A 2 3 4 8 18 21 35 42 44 45 46 48 49 51 53 109 1 141 2801-2805 (852) 2854 3393 (852) 2544 1269 [email protected] 00570 10 8 183 17 1712-16 http://www.winteamgroup.com
目 錄 頁 次 釋 義......................................................... 1 董 事 會 函 件..................................................... 3 言.............
此乃要件 請即處理 閣下如對本通函任何方面或應採取的行動有任何疑問 應諮詢 閣下的股票經紀 其他持牌證 券商 銀行經理 律師 專業會計師或其他專業顧問 閣下如已售出或轉讓名下所有金嗓子控股集團有限公司的股份 應立即將本通函連同隨附的代 表委任表格送交買主或承讓人 或經手買賣的銀行 股票經紀或其他代理人 以便轉交買主或 承讓人 香 交易及結算所有限公司及香 聯合交易所有限公司對本通函的內容概不負責 對其準確性
Ko Yo Ecological Agrotech (Group) Limited 128,000, ,200,000 94,000,000 21,200,000 12,800, Pereire Tod (Asia) Limited 3234
Ko Yo Ecological Agrotech (Group) Limited 128,000,000 115,200,000 94,000,000 21,200,000 12,800,000 0.40 0.70 0.10 8042 Pereire Tod (Asia) Limited 32342C 0.701.0%0.005%0.002% 0.005% 1 2............ www.hkgem.com...
2018 Hope Education Group Co., Ltd
2018 Hope Education Group Co., Ltd. 2018 7 14 2018 8 3 1 2018 Hope Education Group Co., Ltd. 2018 7 14 2018 8 3 2 2018 Hope Education Group Co., Ltd. 2018 7 14 2018 8 3 1 Hope Education Group Co., Ltd.
2008/09 01 2 3 5 6 11 13 22 28 31 33 34 36 39 41 02 WOELM Samuel CPA Clarendon House 2 Church Street Hamilton HM 11 Bermuda 200 17 28 26 1182 (852) 3576 3309 (852) 3576 3963 www.cyfoundation.com 03 57,046
Winning Tower Group Holdings Limited 350,000, ,000,000 70,000, ,000, ,000,000 70,000,000 35,000, % % 0.005% 0.01
Winning Tower Group Holdings Limited 8362 Winning Tower Group Holdings Limited 350,000,000 280,000,000 70,000,000 315,000,000 245,000,000 70,000,000 35,000,000 0.22 0.18 1% 0.0027% 0.005% 0.01 8362 32
i
SINOCHEM HONG KONG HOLDINGS LIMITED i ii iii iv 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54
(i) 179,962, %(ii) 15,638, % 391,200, ,600, %
CHINA CIVIL AVIATION (CAYMAN) INVESTMENT GROUP LIMITED JIA YAO HOLDINGS LIMITED 01626 (1) (2) CHINA CIVIL AVIATION (CAYMAN) INVESTMENT GROUP LIMITED CHINA CIVIL AVIATION (CAYMAN) INVESTMENT GROUP LIMITED
億和精密工業控股有限公司
EVA Precision Industrial Holdings Limited 130,000,000 117,000,000 13,000,000 1.10 0.10 838 32 342C ( ) 1 2........................ 2................................................ 3...........................................
股份代號 :0075 2 3 7 10 11 12 13 15 16 17 1 # * * # * # * # * Albert T. da Rosa, Jr. Clarendon House Church Street Hamilton HM 11 Bermuda 26 3301-07 (852) 2500-5555 (852) 2507-2120 www.ytrealtygroup.com.hk
untitled
1 3 4 7 15 16 22 29 31 32 34 35 37 79 2 FCPA, FCCA FCPA, FCCA Clarendon House 2 Church Street Hamilton HM 11 Bermuda 25 1801 6 The Bank of Bermuda Limited Bank of Bermuda Building 6 Front Street Hamilton
112880.indb
.......... 51.......... 45.......... 54.......... 48............ 40............ 36.......... 66.......... 64.......... 46.......... 34 51 158 16 45 16 54 23 P.T. Sumber Laris Jaya Manufacturer Timber Industry
SHENZHEN HIGH-TECH HOLDINGS LIMITED 106 100% 50% 25 19 1904-1906 132 133 48 1 25 1st Proof 30/06/2006 Shenzhen Hi-Tech 0606139Important(BH) ..................................................................
01565 32,706 14,252 2,002 73.6% 69.5% 77.4% 15 2
2 3-4 5-6 7-9 10-15 16-19 20-60 61-70 71-72 73 74 75-76 77 78-79 80-140 141-146 01565 32,706 14,252 2,002 73.6% 69.5% 77.4% 15 2 15 43 77 3 34 Conyers Dill & Pearman Cricket Square Hutchins Drive P.O.
Information Technology Limited 阿里健康信息技術有限公司 於百慕達註冊成立之有限公司 股份代號 00241 阿里健康信息技術有限公司 中 期 報 告 2017 ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED ALIBABA HEALTH ALIBABA HEALTH Information Technology Limited
China Soft Power Technology Holdings Limited 139 5 22 23 24 25 44 72 I SGM-1 SGM-2 48 183 22 ............................................................ 1......................................................
02 04 06 08 12 14 21 38 42 46 51 67 87 88 89 90 92 93 95 97 148 38.75 10.13 22.81 4,700 680 615,000 1 50,000 7,000 700 2,000 40,000 6,000 600 1,800 1,600 5,000 500 1,400 30,000 4,000 400 1,200 1,000 20,000